Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

Case Presentation: Chronic Oral Anticoagulant and Antiplatelet Management Decisions

Presenter: Walter Desmet, Guy J. Friedrich, Kurt Huber, Eduard Margetic, Oleg Polonetsky

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price

June 22, 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticouagulants

Presentation ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Advertisement

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy

Case Presentation: Chronic Oral Anticoagulant and Antiplatelet Management Decisions

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content